<?xml version="1.0" encoding="UTF-8"?><!--Created by Årsafslutning fra Wolters Kluwer 2025.1--><xbrli:xbrl xmlns:arr="http://xbrl.dcca.dk/arr" xmlns:cmn="http://xbrl.dcca.dk/cmn" xmlns:dst="http://xbrl.dcca.dk/dst" xmlns:entry="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:esg="http://xbrl.dcca.dk/esg" xmlns:frm="http://xbrl.dcca.dk/frm_DanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax" xmlns:fsa="http://xbrl.dcca.dk/fsa" xmlns:gsd="http://xbrl.dcca.dk/gsd" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2010-04-20" xmlns:ixt3="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt5="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mrv="http://xbrl.dcca.dk/mrv" xmlns:sob="http://xbrl.dcca.dk/sob" xmlns:tax="http://xbrl.dcca.dk/tax" xmlns:tch="http://xbrl.dcca.dk/tch" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink"><link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20231001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20231001.xsd" /><xbrli:context id="ID_1"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ID_0"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardDimension"><cmn:memberOfBoardIdentifier>1</cmn:memberOfBoardIdentifier></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="ID_8"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ContributedCapitalMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="ID_10"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ReserveForNetRevaluationAccordingToEquityMethodMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="ID_9"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:RetainedEarningsMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="ID_4"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ID_3"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ID_5"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-01-01</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ContributedCapitalMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="ID_7"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-01-01</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:ReserveForNetRevaluationAccordingToEquityMethodMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="ID_6"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-01-01</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="fsa:ClassesOfEquityDimension">fsa:RetainedEarningsMember</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="ID_2"><xbrli:entity><xbrli:identifier scheme="http://www.dcca.dk/cvr">42544531</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="percent"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="decimal"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="DKK"><xbrli:measure>iso4217:DKK</xbrli:measure></xbrli:unit><xbrli:unit id="Share"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="integer"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="ID_0" xml:lang="en">Simon Louis Théodore Armand Dusséaux</cmn:NameAndSurnameOfMemberOfExecutiveBoard><cmn:TypeOfAuditorAssistance contextRef="ID_1" xml:lang="en">Ingen bistand</cmn:TypeOfAuditorAssistance><fsa:AccountingPoliciesAreUnchangedFromPreviousPeriod contextRef="ID_1" xml:lang="en">true</fsa:AccountingPoliciesAreUnchangedFromPreviousPeriod><fsa:Assets contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">6740947</fsa:Assets><fsa:Assets contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">7003229</fsa:Assets><fsa:AverageNumberOfEmployees contextRef="ID_1" xml:lang="en" unitRef="decimal" decimals="0">0</fsa:AverageNumberOfEmployees><fsa:AverageNumberOfEmployees contextRef="ID_4" xml:lang="en" unitRef="decimal" decimals="0">0</fsa:AverageNumberOfEmployees><fsa:CashAndCashEquivalents contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">16072</fsa:CashAndCashEquivalents><fsa:CashAndCashEquivalents contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">11904</fsa:CashAndCashEquivalents><fsa:ClassOfReportingEntity contextRef="ID_1" xml:lang="en">Regnskabsklasse B</fsa:ClassOfReportingEntity><fsa:ContributedCapital contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">40000</fsa:ContributedCapital><fsa:ContributedCapital contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">40000</fsa:ContributedCapital><fsa:CurrentAssets contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">16072</fsa:CurrentAssets><fsa:CurrentAssets contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">11904</fsa:CurrentAssets><fsa:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="ID_1" xml:lang="en">The financial statement have been prepared under the historical cost principle.
 
Income is recognised in the income statement as it is earned, including value adjustments of financial assets and liabilities that are measured at fair value or amortized cost. Moreover, all expenses incurred to achieve the earnings for the year are recognised in the income statement, including depreciation, amortization, impairment losses and provisions as well as reversals due to changed accounting estimates of amounts that have previously been recognised in the income statement. 
 
Assets are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will accrue to the Company, and the value of the asset can be measured reliably.
 
Liabilities are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will flow out of the Company, and the value of the liability can be measured reliably. 
 
At initial recognition, assets and liabilities are measured at cost. Subsequently, assets and liabilities are measured as described for each item below. 
 
Certain financial assets and liabilities are measured at amortised cost, which involves the recognition of a constant effective interest rate over the term. Amortised cost is calculated as original cost less repayments and with the addition/deduction of the accumulated amortisation of the difference between the cost and the nominal amount. This way, exchange losses and gains are allocated over the term. 
 
In connection with recognition and measurement, consideration is given to predictable losses and risks occurring prior to the presentation of the financial statement, i.e. losses and risks which prove or disprove matters which exist at the balance sheet date.
 , Basis of recognition and measurement
The financial statement have been prepared under the historical cost principle.
 
Income is recognised in the income statement as it is earned, including value adjustments of financial assets and liabilities that are measured at fair value or amortized cost. Moreover, all expenses incurred to achieve the earnings for the year are recognised in the income statement, including depreciation, amortization, impairment losses and provisions as well as reversals due to changed accounting estimates of amounts that have previously been recognised in the income statement. 
 
Assets are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will accrue to the Company, and the value of the asset can be measured reliably.
 
Liabilities are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will flow out of the Company, and the value of the liability can be measured reliably. 
 
At initial recognition, assets and liabilities are measured at cost. Subsequently, assets and liabilities are measured as described for each item below. 
 
Certain financial assets and liabilities are measured at amortised cost, which involves the recognition of a constant effective interest rate over the term. Amortised cost is calculated as original cost less repayments and with the addition/deduction of the accumulated amortisation of the difference between the cost and the nominal amount. This way, exchange losses and gains are allocated over the term. 
 
In connection with recognition and measurement, consideration is given to predictable losses and risks occurring prior to the presentation of the financial statement, i.e. losses and risks which prove or disprove matters which exist at the balance sheet date.
 </fsa:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates contextRef="ID_1" xml:lang="en">Investments in group enterprises and associates are recognized in the balance sheet at the proportionate share of the equity value of the enterprises, calculated according to the parent Company's  accounting policies with the deduction or addition of unrealised intercompany profits or losses and with the addition or deduction of the remaining value of positive or negative goodwill, calculated according to the purchase method.
 
Subsidiaries having a negative equity value are recognised at kr. 0, and any amounts receivable from those enterprises are written down by the parent Company's share of the negative equity value to the extent that the amounts are deemed to be uncollectible.
 
If the negative equity value exceeds receivables, the remaining amount is recognised as a provision to the extent that the parent Company has a legal or constructive obligation to cover the negative balance of the relevant subsidiary., Equity investments in group enterprises and associates
Investments in group enterprises and associates are recognized in the balance sheet at the proportionate share of the equity value of the enterprises, calculated according to the parent Company's  accounting policies with the deduction or addition of unrealised intercompany profits or losses and with the addition or deduction of the remaining value of positive or negative goodwill, calculated according to the purchase method.
 
Subsidiaries having a negative equity value are recognised at kr. 0, and any amounts receivable from those enterprises are written down by the parent Company's share of the negative equity value to the extent that the amounts are deemed to be uncollectible.
 
If the negative equity value exceeds receivables, the remaining amount is recognised as a provision to the extent that the parent Company has a legal or constructive obligation to cover the negative balance of the relevant subsidiary.</fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfAssetsAndLiabilities contextRef="ID_1" xml:lang="en">Balance sheet
 
Equity investments in group enterprises and associates
Investments in group enterprises and associates are recognized in the balance sheet at the proportionate share of the equity value of the enterprises, calculated according to the parent Company's  accounting policies with the deduction or addition of unrealised intercompany profits or losses and with the addition or deduction of the remaining value of positive or negative goodwill, calculated according to the purchase method.
 
Subsidiaries having a negative equity value are recognised at kr. 0, and any amounts receivable from those enterprises are written down by the parent Company's share of the negative equity value to the extent that the amounts are deemed to be uncollectible.
 
If the negative equity value exceeds receivables, the remaining amount is recognised as a provision to the extent that the parent Company has a legal or constructive obligation to cover the negative balance of the relevant subsidiary.

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand as well as short-term securities with a term of less than three months which can be converted directly into cash at bank and in hand and involve only an insignificant risk of value changes.
 
Equity
Equity comprises the working capital and a number of equity items that may be statutory or stipulated in the articles of association.

Deferred tax
Deferred tax and the associated adjustments for the year are determined according to the liability method as the tax base of all temporary differences between carrying amounts and the tax bases of assets and liabilities. 
 
Deferred tax assets, including the tax base of tax losses allowed for carryforward, are recognised at the value at which they are expected to be used, either by elimination in tax on future earnings or by set-off against deferred tax liabilities in enterprises within the same legal entity and jurisdiction.
 
Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation applicable at the balance sheet date when the deferred tax is expected to crystallize as current tax.
 
Liabilities
Financial liabilities are recognised initially at the proceeds received net of transaction expenses incurred. In subsequent periods, financial liabilities are measured at amortized cost, corresponding to the capitalized value using the effective interest method, so that the difference between the proceeds and the nominal value is recognised in the income statement over the life of the financial instrument.
 
Mortgage debt is accordingly measured at amortized cost, corresponding to the outstanding balance in case of cash loans. In case of bond loans, amortized cost corresponds to the outstanding balance determined as the underlying cash value of the loans at the time of borrowing adjusted for amortisation of capital losses on the loans over the repayment period.
 
Other liabilities are measured at net realisable value. 
 
Contingent assets and liabilities
Contingent assets and liabilities are not recognised in the Balance Sheet but appear only in the notes.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfAssetsAndLiabilities><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="ID_1" xml:lang="en">Cash and cash equivalents comprise cash at bank and in hand as well as short-term securities with a term of less than three months which can be converted directly into cash at bank and in hand and involve only an insignificant risk of value changes.
 , Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand as well as short-term securities with a term of less than three months which can be converted directly into cash at bank and in hand and involve only an insignificant risk of value changes.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity contextRef="ID_1" xml:lang="en">Equity comprises the working capital and a number of equity items that may be statutory or stipulated in the articles of association., Equity
Equity comprises the working capital and a number of equity items that may be statutory or stipulated in the articles of association.
</fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="ID_1" xml:lang="en">Other external expenses include expenses for distribution, sales, advertising, administration, premises, bad debts, operating leasing expenses etc.
 , Other external expenses
Other external expenses include expenses for distribution, sales, advertising, administration, premises, bad debts, operating leasing expenses etc.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="ID_1" xml:lang="en">Financial income and expenses
Financial income and expenses are recognised in the income statement based at the amounts that concern the financial year. Financial income and expenses include interest revenue and expenses, financial expenses of finance leases, realised and unrealised capital gains and losses regarding securities, accounts payable and transactions in foreign currencies, repayment on mortgage loans, and surcharges and allowances under the advance-payment of tax scheme.
 
Dividends from other investments are recognised as income in the financial year in which the dividends are declared.
 , Financial income and expenses are recognised in the income statement based at the amounts that concern the financial year. Financial income and expenses include interest revenue and expenses, financial expenses of finance leases, realised and unrealised capital gains and losses regarding securities, accounts payable and transactions in foreign currencies, repayment on mortgage loans, and surcharges and allowances under the advance-payment of tax scheme.
 
Dividends from other investments are recognised as income in the financial year in which the dividends are declared.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="ID_1" xml:lang="en">Income from investments in group enterprises and associates
Income from equity investments comprises the proportionate share of profit/loss after tax and any adjustment of internal profit/loss and less amortization of consolidated goodwill.
 , Income from equity investments comprises the proportionate share of profit/loss after tax and any adjustment of internal profit/loss and less amortization of consolidated goodwill.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeStatementItems contextRef="ID_1" xml:lang="en">Income statement
 
Other external expenses
Other external expenses include expenses for distribution, sales, advertising, administration, premises, bad debts, operating leasing expenses etc.
 
Income from investments in group enterprises and associates
Income from equity investments comprises the proportionate share of profit/loss after tax and any adjustment of internal profit/loss and less amortization of consolidated goodwill.
 
Financial income and expenses
Financial income and expenses are recognised in the income statement based at the amounts that concern the financial year. Financial income and expenses include interest revenue and expenses, financial expenses of finance leases, realised and unrealised capital gains and losses regarding securities, accounts payable and transactions in foreign currencies, repayment on mortgage loans, and surcharges and allowances under the advance-payment of tax scheme.
 
Dividends from other investments are recognised as income in the financial year in which the dividends are declared.
 
Tax on net profit for the year
Tax on net profit/loss for the year comprises current tax on expected taxable income of the year and the year's adjustment of deferred tax less the part of the tax of the year that relates to changes in equity. Current and deferred tax regarding changes in equity is recognised directly in equity.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeStatementItems><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="ID_1" xml:lang="en">Liabilities
Financial liabilities are recognised initially at the proceeds received net of transaction expenses incurred. In subsequent periods, financial liabilities are measured at amortized cost, corresponding to the capitalized value using the effective interest method, so that the difference between the proceeds and the nominal value is recognised in the income statement over the life of the financial instrument.
 
Mortgage debt is accordingly measured at amortized cost, corresponding to the outstanding balance in case of cash loans. In case of bond loans, amortized cost corresponds to the outstanding balance determined as the underlying cash value of the loans at the time of borrowing adjusted for amortisation of capital losses on the loans over the repayment period.
 
Other liabilities are measured at net realisable value. 
 , Financial liabilities are recognised initially at the proceeds received net of transaction expenses incurred. In subsequent periods, financial liabilities are measured at amortized cost, corresponding to the capitalized value using the effective interest method, so that the difference between the proceeds and the nominal value is recognised in the income statement over the life of the financial instrument.
 
Mortgage debt is accordingly measured at amortized cost, corresponding to the outstanding balance in case of cash loans. In case of bond loans, amortized cost corresponds to the outstanding balance determined as the underlying cash value of the loans at the time of borrowing adjusted for amortisation of capital losses on the loans over the repayment period.
 
Other liabilities are measured at net realisable value. 
 , Contingent assets and liabilities
Contingent assets and liabilities are not recognised in the Balance Sheet but appear only in the notes.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfProvisions contextRef="ID_1" xml:lang="en">Deferred tax
Deferred tax and the associated adjustments for the year are determined according to the liability method as the tax base of all temporary differences between carrying amounts and the tax bases of assets and liabilities. 
 
Deferred tax assets, including the tax base of tax losses allowed for carryforward, are recognised at the value at which they are expected to be used, either by elimination in tax on future earnings or by set-off against deferred tax liabilities in enterprises within the same legal entity and jurisdiction.
 
Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation applicable at the balance sheet date when the deferred tax is expected to crystallize as current tax.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfProvisions><fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="ID_1" xml:lang="en">Tax on net profit/loss for the year comprises current tax on expected taxable income of the year and the year's adjustment of deferred tax less the part of the tax of the year that relates to changes in equity. Current and deferred tax regarding changes in equity is recognised directly in equity.
 , Tax on net profit for the year
Tax on net profit/loss for the year comprises current tax on expected taxable income of the year and the year's adjustment of deferred tax less the part of the tax of the year that relates to changes in equity. Current and deferred tax regarding changes in equity is recognised directly in equity.
 </fsa:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><fsa:DisclosureOfAccountingPolicies contextRef="ID_1" xml:lang="en"> 
 
Reporting Class
The annual report of SDBIO ApS for 2024 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B.
 
The accounting policies applied remain unchanged from last year.
 
Reporting currency
The annual report is presented in Danish kroner.
 
General information
 
Basis of recognition and measurement
The financial statement have been prepared under the historical cost principle.
 
Income is recognised in the income statement as it is earned, including value adjustments of financial assets and liabilities that are measured at fair value or amortized cost. Moreover, all expenses incurred to achieve the earnings for the year are recognised in the income statement, including depreciation, amortization, impairment losses and provisions as well as reversals due to changed accounting estimates of amounts that have previously been recognised in the income statement. 
 
Assets are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will accrue to the Company, and the value of the asset can be measured reliably.
 
Liabilities are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will flow out of the Company, and the value of the liability can be measured reliably. 
 
At initial recognition, assets and liabilities are measured at cost. Subsequently, assets and liabilities are measured as described for each item below. 
 
Certain financial assets and liabilities are measured at amortised cost, which involves the recognition of a constant effective interest rate over the term. Amortised cost is calculated as original cost less repayments and with the addition/deduction of the accumulated amortisation of the difference between the cost and the nominal amount. This way, exchange losses and gains are allocated over the term. 
 
In connection with recognition and measurement, consideration is given to predictable losses and risks occurring prior to the presentation of the financial statement, i.e. losses and risks which prove or disprove matters which exist at the balance sheet date.
 
Income statement
 
Other external expenses
Other external expenses include expenses for distribution, sales, advertising, administration, premises, bad debts, operating leasing expenses etc.
 
Income from investments in group enterprises and associates
Income from equity investments comprises the proportionate share of profit/loss after tax and any adjustment of internal profit/loss and less amortization of consolidated goodwill.
 
Financial income and expenses
Financial income and expenses are recognised in the income statement based at the amounts that concern the financial year. Financial income and expenses include interest revenue and expenses, financial expenses of finance leases, realised and unrealised capital gains and losses regarding securities, accounts payable and transactions in foreign currencies, repayment on mortgage loans, and surcharges and allowances under the advance-payment of tax scheme.
 
Dividends from other investments are recognised as income in the financial year in which the dividends are declared.
 
Tax on net profit for the year
Tax on net profit/loss for the year comprises current tax on expected taxable income of the year and the year's adjustment of deferred tax less the part of the tax of the year that relates to changes in equity. Current and deferred tax regarding changes in equity is recognised directly in equity.
 
Balance sheet
 
Equity investments in group enterprises and associates
Investments in group enterprises and associates are recognized in the balance sheet at the proportionate share of the equity value of the enterprises, calculated according to the parent Company's  accounting policies with the deduction or addition of unrealised intercompany profits or losses and with the addition or deduction of the remaining value of positive or negative goodwill, calculated according to the purchase method.
 
Subsidiaries having a negative equity value are recognised at kr. 0, and any amounts receivable from those enterprises are written down by the parent Company's share of the negative equity value to the extent that the amounts are deemed to be uncollectible.
 
If the negative equity value exceeds receivables, the remaining amount is recognised as a provision to the extent that the parent Company has a legal or constructive obligation to cover the negative balance of the relevant subsidiary.

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand as well as short-term securities with a term of less than three months which can be converted directly into cash at bank and in hand and involve only an insignificant risk of value changes.
 
Equity
Equity comprises the working capital and a number of equity items that may be statutory or stipulated in the articles of association.

Deferred tax
Deferred tax and the associated adjustments for the year are determined according to the liability method as the tax base of all temporary differences between carrying amounts and the tax bases of assets and liabilities. 
 
Deferred tax assets, including the tax base of tax losses allowed for carryforward, are recognised at the value at which they are expected to be used, either by elimination in tax on future earnings or by set-off against deferred tax liabilities in enterprises within the same legal entity and jurisdiction.
 
Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation applicable at the balance sheet date when the deferred tax is expected to crystallize as current tax.
 
Liabilities
Financial liabilities are recognised initially at the proceeds received net of transaction expenses incurred. In subsequent periods, financial liabilities are measured at amortized cost, corresponding to the capitalized value using the effective interest method, so that the difference between the proceeds and the nominal value is recognised in the income statement over the life of the financial instrument.
 
Mortgage debt is accordingly measured at amortized cost, corresponding to the outstanding balance in case of cash loans. In case of bond loans, amortized cost corresponds to the outstanding balance determined as the underlying cash value of the loans at the time of borrowing adjusted for amortisation of capital losses on the loans over the repayment period.
 
Other liabilities are measured at net realisable value. 
 
Contingent assets and liabilities
Contingent assets and liabilities are not recognised in the Balance Sheet but appear only in the notes.
 </fsa:DisclosureOfAccountingPolicies><fsa:DisclosureOfContingentLiabilities contextRef="ID_1" xml:lang="en">3. Contingent liabilities
No contingent liabilities exist at the balance sheet date.
 

</fsa:DisclosureOfContingentLiabilities><fsa:DisclosureOfEmployeeBenefitsExpense contextRef="ID_1" xml:lang="en">1. Employee benefits expense
Average number of employees	0	 	0
 	 	 	 
</fsa:DisclosureOfEmployeeBenefitsExpense><fsa:DisclosureOfEquity contextRef="ID_1" xml:lang="en">
 	 	 	 	 	 	Reserve for	 	 
 	 	 	 	 	 	net reva-	 	 
 	 	 	 	 	 	luation ac-	 	 
 	 	 	 	 	 	cording to	 	 
 	 	Contributed	 	Retained	 	equity	 	 
 	 	capital	 	earnings	 	method	 	Total
Equity 1 January 2024	 	40.000	 	-8.264	 	6.709.211	 	6.740.947
Profit (loss)	 	0	 	-3.280	 	0	 	-3.280
Revaluations	 	0	 	0	 	265.562	 	265.562
Equity 31 December 2024	 	40.000	 	-11.544	 	6.974.773	 	7.003.229
 
</fsa:DisclosureOfEquity><fsa:DisclosureOfInvestments contextRef="ID_1" xml:lang="en">2. Disclosure in long-term investments in participating interests
Participating interests	 	 
Name	Registered office	Share held %
EvodiaBio ApS	Rødovre	13,33
 	 	 
</fsa:DisclosureOfInvestments><fsa:DisclosureOfMortgagesAndCollaterals contextRef="ID_1" xml:lang="en">4. Collaterals and securities
No securities or mortgages exist at the balance sheet date.
 
</fsa:DisclosureOfMortgagesAndCollaterals><fsa:Equity contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">6740947</fsa:Equity><fsa:Equity contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">7003229</fsa:Equity><fsa:Equity contextRef="ID_5" xml:lang="en" unitRef="DKK" decimals="0">-40000</fsa:Equity><fsa:Equity contextRef="ID_6" xml:lang="en" unitRef="DKK" decimals="0">8264</fsa:Equity><fsa:Equity contextRef="ID_7" xml:lang="en" unitRef="DKK" decimals="0">-6709211</fsa:Equity><fsa:GrossProfitLoss contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">-4168</fsa:GrossProfitLoss><fsa:GrossProfitLoss contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">-5339</fsa:GrossProfitLoss><fsa:IncomeFromInvestmentsInGroupEnterprisesAndAssociates contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">265533</fsa:IncomeFromInvestmentsInGroupEnterprisesAndAssociates><fsa:IncomeFromInvestmentsInGroupEnterprisesAndAssociates contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">13333</fsa:IncomeFromInvestmentsInGroupEnterprisesAndAssociates><fsa:InformationOnReportingClassOfEntity contextRef="ID_1" xml:lang="en">The annual report of SDBIO ApS for 2024 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B.
 </fsa:InformationOnReportingClassOfEntity><fsa:LiabilitiesAndEquity contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">6740947</fsa:LiabilitiesAndEquity><fsa:LiabilitiesAndEquity contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">7003229</fsa:LiabilitiesAndEquity><fsa:LongtermInvestmentsAndReceivables contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">6724875</fsa:LongtermInvestmentsAndReceivables><fsa:LongtermInvestmentsAndReceivables contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">6991325</fsa:LongtermInvestmentsAndReceivables><fsa:LongtermInvestmentsInAssociates contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">6722544</fsa:LongtermInvestmentsInAssociates><fsa:LongtermInvestmentsInAssociates contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">6988077</fsa:LongtermInvestmentsInAssociates><fsa:NoncurrentAssets contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">6724875</fsa:NoncurrentAssets><fsa:NoncurrentAssets contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">6991325</fsa:NoncurrentAssets><fsa:NoncurrentDeferredTaxAssets contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">2331</fsa:NoncurrentDeferredTaxAssets><fsa:NoncurrentDeferredTaxAssets contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">3248</fsa:NoncurrentDeferredTaxAssets><fsa:ProfitLoss contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">262282</fsa:ProfitLoss><fsa:ProfitLoss contextRef="ID_10" xml:lang="en" unitRef="DKK" decimals="0">0</fsa:ProfitLoss><fsa:ProfitLoss contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">9169</fsa:ProfitLoss><fsa:ProfitLoss contextRef="ID_8" xml:lang="en" unitRef="DKK" decimals="0">0</fsa:ProfitLoss><fsa:ProfitLoss contextRef="ID_9" xml:lang="en" unitRef="DKK" decimals="0">-3280</fsa:ProfitLoss><fsa:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">261365</fsa:ProfitLossFromOrdinaryActivitiesBeforeTax><fsa:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">7994</fsa:ProfitLossFromOrdinaryActivitiesBeforeTax><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">-4168</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ProfitLossFromOrdinaryOperatingActivities contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">-5339</fsa:ProfitLossFromOrdinaryOperatingActivities><fsa:ReserveForNetRevaluationAccordingToEquityMethod contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">6709211</fsa:ReserveForNetRevaluationAccordingToEquityMethod><fsa:ReserveForNetRevaluationAccordingToEquityMethod contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">6974773</fsa:ReserveForNetRevaluationAccordingToEquityMethod><fsa:RetainedEarnings contextRef="ID_2" xml:lang="en" unitRef="DKK" decimals="0">-8264</fsa:RetainedEarnings><fsa:RetainedEarnings contextRef="ID_3" xml:lang="en" unitRef="DKK" decimals="0">-11544</fsa:RetainedEarnings><fsa:Revaluations contextRef="ID_10" xml:lang="en" unitRef="DKK" decimals="0">-265562</fsa:Revaluations><fsa:Revaluations contextRef="ID_8" xml:lang="en" unitRef="DKK" decimals="0">0</fsa:Revaluations><fsa:Revaluations contextRef="ID_9" xml:lang="en" unitRef="DKK" decimals="0">0</fsa:Revaluations><fsa:SelectedElementsFromReportingClassC contextRef="ID_1" xml:lang="en">false</fsa:SelectedElementsFromReportingClassC><fsa:TaxExpense contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">-917</fsa:TaxExpense><fsa:TaxExpense contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">-1175</fsa:TaxExpense><fsa:TransferredToFromReserveForNetRevaluationAccordingToEquityMethod contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">-265562</fsa:TransferredToFromReserveForNetRevaluationAccordingToEquityMethod><fsa:TransferredToFromReserveForNetRevaluationAccordingToEquityMethod contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">-13333</fsa:TransferredToFromReserveForNetRevaluationAccordingToEquityMethod><fsa:TransferredToFromRetainedEarnings contextRef="ID_1" xml:lang="en" unitRef="DKK" decimals="0">3280</fsa:TransferredToFromRetainedEarnings><fsa:TransferredToFromRetainedEarnings contextRef="ID_4" xml:lang="en" unitRef="DKK" decimals="0">4164</fsa:TransferredToFromRetainedEarnings><gsd:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="ID_1" xml:lang="en">Silkeborg, 8600</gsd:AddressOfSubmittingEnterprisePostcodeAndTown><gsd:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="ID_1" xml:lang="en">Papirfabrikken 52, 18. 3</gsd:AddressOfSubmittingEnterpriseStreetAndNumber><gsd:DateOfFoundationOfReportingEntity contextRef="ID_1" xml:lang="en">2021-07-13</gsd:DateOfFoundationOfReportingEntity><gsd:DateOfGeneralMeeting contextRef="ID_1" xml:lang="en">2025-05-15</gsd:DateOfGeneralMeeting><gsd:IdentificationNumberCvrOfReportingEntity contextRef="ID_1" xml:lang="en">42544531</gsd:IdentificationNumberCvrOfReportingEntity><gsd:IdentificationNumberCvrOfSubmittingEnterprise contextRef="ID_1" xml:lang="en">40147721</gsd:IdentificationNumberCvrOfSubmittingEnterprise><gsd:InformationOnTypeOfSubmittedReport contextRef="ID_1" xml:lang="en">Årsrapport</gsd:InformationOnTypeOfSubmittedReport><gsd:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="ID_1" xml:lang="en">Simon Louis Théodore Armand Dusséaux</gsd:NameAndSurnameOfChairmanOfGeneralMeeting><gsd:NameOfReportingEntity contextRef="ID_1" xml:lang="en">SDBIO ApS</gsd:NameOfReportingEntity><gsd:NameOfSubmittingEnterprise contextRef="ID_1" xml:lang="en">Accountview ApS</gsd:NameOfSubmittingEnterprise><gsd:PrecedingReportingPeriodStartDate contextRef="ID_1" xml:lang="en">2023-01-01</gsd:PrecedingReportingPeriodStartDate><gsd:PredingReportingPeriodEndDate contextRef="ID_1" xml:lang="en">2023-12-31</gsd:PredingReportingPeriodEndDate><gsd:ReportingPeriodEndDate contextRef="ID_1" xml:lang="en">2024-12-31</gsd:ReportingPeriodEndDate><gsd:ReportingPeriodStartDate contextRef="ID_1" xml:lang="en">2024-01-01</gsd:ReportingPeriodStartDate><mrv:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="ID_1" xml:lang="en">The Company's Income Statement of the financial year 1 January 2024 - 31 December 2024 shows a result of DKK 262.282 and the Balance Sheet at 31 December 2024 a balance sheet total of DKK 7.003.229 and an equity of DKK 7.003.229.
 , Development in the activities and the financial situation of the Company
The Company's Income Statement of the financial year 1 January 2024 - 31 December 2024 shows a result of DKK 262.282 and the Balance Sheet at 31 December 2024 a balance sheet total of DKK 7.003.229 and an equity of DKK 7.003.229.
 </mrv:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs><mrv:DescriptionOfPrimaryActivitiesOfEntity contextRef="ID_1" xml:lang="en">The Company's principal activities
The Company's principal activities consist in owning capital shares as well as other activies in connection to this.
 </mrv:DescriptionOfPrimaryActivitiesOfEntity><mrv:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod contextRef="ID_1" xml:lang="en">Post financial year events
After the end of the financial year, no events have occurred which may change the financial position of the entity substantially.
 </mrv:DescriptionOfSignificantEventsOccurringAfterEndOfReportingPeriod><mrv:ManagementsReview contextRef="ID_1" xml:lang="en">The Company's principal activities
The Company's principal activities consist in owning capital shares as well as other activies in connection to this.
 
Development in the activities and the financial situation of the Company
The Company's Income Statement of the financial year 1 January 2024 - 31 December 2024 shows a result of DKK 262.282 and the Balance Sheet at 31 December 2024 a balance sheet total of DKK 7.003.229 and an equity of DKK 7.003.229.
 
Post financial year events
After the end of the financial year, no events have occurred which may change the financial position of the entity substantially.
 </mrv:ManagementsReview><sob:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="ID_1" xml:lang="en">The Annual Report is presented in accordance with the Danish Financial Statements Act.
 </sob:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><sob:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="ID_1" xml:lang="en">In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2024 and of the results of the Company's operations for the financial year 1 January 2024 - 31 December 2024.
 </sob:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><sob:ConfirmationThatFinancialStatementsAreExemptedFromAuditing contextRef="ID_1" xml:lang="en">The conditions for not conducting an audit of the Financial Statement have been met.
 </sob:ConfirmationThatFinancialStatementsAreExemptedFromAuditing><sob:DateOfApprovalOfAnnualReport contextRef="ID_1" xml:lang="en">2025-05-15</sob:DateOfApprovalOfAnnualReport><sob:IdentificationOfApprovedAnnualReport contextRef="ID_1" xml:lang="en">Today, Management has considered and adopted the Annual Report of SDBIO ApS for the financial year 1 January 2024 - 31 December 2024.
 </sob:IdentificationOfApprovedAnnualReport><sob:ManagementsStatementAboutManagementsReview contextRef="ID_1" xml:lang="en">In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review.
 </sob:ManagementsStatementAboutManagementsReview><sob:PlaceOfSignatureOfStatement contextRef="ID_1" xml:lang="en">København V</sob:PlaceOfSignatureOfStatement><sob:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="ID_1" xml:lang="en">We recommend that the Annual Report be adopted at the Annual General Meeting.
 </sob:RecommendationForApprovalOfAnnualReportByGeneralMeeting><sob:StatementByExecutiveAndSupervisoryBoards contextRef="ID_1" xml:lang="en">
Today, Management has considered and adopted the Annual Report of SDBIO ApS for the financial year 1 January 2024 - 31 December 2024.
 
The Annual Report is presented in accordance with the Danish Financial Statements Act.
 
In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2024 and of the results of the Company's operations for the financial year 1 January 2024 - 31 December 2024.
 
In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review.
 
The conditions for not conducting an audit of the Financial Statement have been met.
 
We recommend that the Annual Report be adopted at the Annual General Meeting.
 
 
København V, 15 May 2025
 
Executive Board
 
 
 
Simon Louis Théodore Armand Dusséaux
	 
 
 
 
 
 
	 
 
 
 
 
 

CEO	 	 
 	 	 
</sob:StatementByExecutiveAndSupervisoryBoards></xbrli:xbrl>